CLINICAL TRIAL / NCT01526096

Stem Cell Transplantation for Patients With Multiple Myeloma

  • Interventional
  • Active
  • NCT01526096

Pilot Study T Cell Depletion in the Setting of Autologous Stem Cell Transplantation for Patients With Multiple Myeloma

The purpose of this study is to test whether regulatory T-cell reduction is possible and safe in myeloma subjects undergoing autologous stem cell transplantation (ASCT).